TheFly.com
APLS
Apellis
$
()
Apellis appoints Philip Ferrone as chief medical retina advisor
Apellis price target raised by $2 at UBS, here's why
Apellis price target raised by $7 at Wedbush, here's why
Apellis price target raised by $7 at BofA, here's why
Apellis price target raised by $19 at Baird, here's why
Apellis expects cash to fund expenditures for 'foreseeable future'
Apellis reports Q4 EPS (73c), consensus (69c)
Apellis price target raised by $11 at Mizuho, here's why
Apellis price target raised by $17 at UBS, here's why
Apellis price target raised by $4 at Raymond James, here's why
Apellis just upgraded at Jefferies, here's why
Apellis price target raised by $4 at Oppenheimer, here's why
Copyright ©1998-2024 Thefly.com LLC
